Faculty Disclosures
|
No disclosure on file
|
| Andrew D. Goodman, MD, FAAN |
Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Swan Bio. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IMCYSE. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Pfizer. The institution of Dr. Goodman has received research support from Atara. The institution of Dr. Goodman has received research support from Genzyme. The institution of Dr. Goodman has received research support from EMD-Serono. |
| Paul W. O'Connor, MD |
No disclosure on file
|
| Richard A. Rudick, MD, FAAN |
Dr. Rudick has received personal compensation for serving as an employee of Biogen. Dr. Rudick has received stock or an ownership interest from Biogen. Dr. Rudick has received publishing royalties from a publication relating to health care. |
| Alfred W. Sandrock, MD, PhD |
No disclosure on file
|
| Brigitte Wildemann, MD |
Dr. Wildemann has nothing to disclose. |
| Claudia F. Lucchinetti, MD, FAAN |
The institution of Dr. Lucchinetti has received research support from Biogen Idec. The institution of Dr. Lucchinetti has received research support from NIH/NINDS. The institution of Dr. Lucchinetti has received research support from National Institute of Neurological Disorders and Stroke . The institution of Dr. Lucchinetti has received research support from National Multiple Sclerosis Society. The institution of Dr. Lucchinetti has received research support from National Center for Advancing Translational Sciences. Dr. Lucchinetti has received intellectual property interests from a discovery or technology relating to health care. Dr. Lucchinetti has a non-compensated relationship as a Member with National Institute of Neurological Disorders that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Board of Directors, Association of University Professors of Neurology that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Mayo Clinic Board of Trustees that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Mayo Clinic Board of Governors that is relevant to AAN interests or activities. |
| Joseph E. Parisi, MD |
Dr. Parisi has nothing to disclose. |
| Hayrettin Tumani, MD |
Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. |
| Chris H. Polman, MD |
No disclosure on file
|
| Andrew H. Chan, MD |
No disclosure on file
|
| Susan E. Goelz, PhD |
No disclosure on file
|
| Diego Franciotta, MD |
Dr. Franciotta has nothing to disclose. |
| Hollie K. Schmidt |
Ms. Schmidt has received personal compensation for serving as an employee of Accelerated Cure Project for MS. |
| Fiona Forrestal |
No disclosure on file
|
| Marie Fleury |
No disclosure on file
|
| Sven O. Jarius, MD |
Dr. Jarius has nothing to disclose. |
| Johannes Brettschneider, MD |
No disclosure on file
|
| Frederic Blanc |
No disclosure on file
|
| Ling L. Chen, PhD |
No disclosure on file
|
| Jayawant N. Mandrekar, PhD |
Dr. Mandrekar has nothing to disclose. |
| Stephanie Jurgensen, PhD |
No disclosure on file
|
| Leonid Gorelik, PhD |
No disclosure on file
|
| Wolfgang Brueck, PhD |
Dr. Brueck has nothing to disclose. |
| Nicolas Collongues, MD |
Nicolas Collongues, MD has nothing to disclose. |
| Jean Baptiste Chanson |
No disclosure on file
|
| Josa Frischer |
No disclosure on file
|
| Meena Subramanyam, PhD |
No disclosure on file
|
| Nir Dotan |
No disclosure on file
|
| Soma S. Ray |
Soma S. Ray has received personal compensation for serving as an employee of Dyne Therapeutics. Soma S. Ray has stock in Dyne Therapeutics. |
| Sonya U. Steele, MD |
No disclosure on file
|
| Luis Querol, MD, PhD |
Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. The institution of Dr. Querol has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. The institution of Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Grifols. The institution of Dr. Querol has received research support from GBS-CIDP Foundation International. The institution of Dr. Querol has received research support from Grifols. The institution of Dr. Querol has received research support from ISCIII. The institution of Dr. Querol has received research support from CIBERER. The institution of Dr. Querol has received research support from UCB. |
| Stephen Weigand |
Stephen Weigand has nothing to disclose. |